Death of Construction Partners Director Michael McKay Triggers Nasdaq Audit Committee Non-Compliance

summarizeSummary

Construction Partners disclosed the death of director Michael McKay, leaving its Audit Committee with only two independent directors and triggering a Nasdaq listing rule deficiency. The company has a cure period to appoint a new director. It also issued 619,000 restricted shares to employees.

check_boxKey Events · Executive and Board Changes · ROAD

• Director Death Triggers Nasdaq Non-Compliance

  Founding director Michael H. McKay died on July 22, 2026, reducing the Audit Committee to two independent directors and causing non-compliance with Nasdaq Listing Rule 5605(c)(2)(A).

• Cure Period Until July 2027

  The company has until its next annual meeting or July 22, 2027, to appoint a new independent director and regain compliance. It intends to do so within that period.

• 619,000 Restricted Shares Issued to Employees

  On August 6, 2026, the company issued 619,000 restricted shares of Class B common stock to employees, vesting on September 30, 2030, under the 2024 Restricted Stock Plan.

auto_awesomeAnalysis · ROAD · Real Estate & Construction

The passing of founding director Michael McKay leaves the Audit Committee with only two independent directors, putting the company out of compliance with Nasdaq listing rules. A cure period extends until the next annual meeting or July 22, 2027, to appoint a new independent director and regain compliance. While management expresses confidence in meeting this deadline, the loss of a long-tenured director with deep financial expertise represents a governance setback. Separately, the company issued 619,000 restricted shares to employees—a modest equity grant that does not materially dilute existing holders.